Clinical trial
Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or…
NCT00054392 · Fox Chase Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00054392 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer |
| Official title | A Randomized, Phase III Multicenter Trial Of Gemcitabine In Combination With Carboplatin Or Paclitaxel Plus Carboplatin In Patients With Metastatic (Stage IIIB, IV) Non-Small Cell Lung Cancer |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, gemcitabine hydrochloride, paclitaxel |
| Enrollment | 0 |
| Start date | Sep 1, 2001 |
| Primary completion | Sep 1, 2001 |
| Completion | Sep 1, 2001 |
| First posted | Feb 6, 2003 |
| Last update posted | Jul 11, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: